Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Intelliseq logo — Master Genomic Analysis: User-Friendly, Adaptable & Comprehe...

Intelliseq

Master Genomic Analysis: User-Friendly, Adaptable & Comprehensive solution for Professionals

Founded 2013 18 employees Venture round Total: $23.50M AI, Analytics +2

General Information

Company Name Intelliseq
Founded Year 2013
Employees 18
Industries AI, Analytics, Biotechnology +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Intelliseq. To contact Intelliseq, visit intelliseq.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Intelliseq

Intelliseq, founded in 2013, is a pioneering company in the field of next generation sequencing, specializing in AI, analytics, biotechnology, and healthcare. The company's slogan, "Master Genomic Analysis: User-Friendly, Adaptable & Comprehensive solution for Professionals," encapsulates its commitment to providing cutting-edge solutions for genomic analysis. With a recent PLN7.50M Venture Round investment on 07 November 2022, the company has received backing from prominent investors including Cobin Angels and Unfold.vc. Intelliseq's team, comprising passionate and skilled bioinformaticians, geneticists, and molecular biologists, is known for its creativity and flexibility in tackling the challenges of next generation DNA sequencing. This places Intelliseq at the forefront of innovation, with a strong potential for growth and impact in the biotechnology and healthcare industries.

Taxonomy: Genomic Analysis, Next Generation Sequencing, Bioinformatics, Genetics, Molecular Biology, DNA Sequencing, Bioinformaticians, Geneticists, Professional Solutions, Adaptable, Comprehensive, User-Friendly, State of the Art, Intelliseq

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture round €4.50M 4
Vinci HiTech, Unfold.vc +2
28 Mar 2025
Seed Round PLN9.50M 1
YouNick
YouNick
07 Nov 2022
Venture Round PLN7.50M 2
Cobin Angels, Unfold.vc
07 Nov 2022
Non Equity Assistance Undisclosed 1
Google for Startups
01 Apr 2021
Seed Round PLN2.00M 1
Unfold.vc
29 Mar 2018

Latest News

View All
Intelliseq secures €4.5M to enhance DNA analysis and genetic diagnostics — Tech
Intelliseq secures €4.5M to enhance DNA analysis and genetic diagnostics
Tech Mar 28, 2025

Intelliseq Alternatives & Competitors

View All Alternatives
Intelliseq vs
Personal Genome Diagnostics
Personal Genome Diagnostics

Leading the way in patient-specific cancer genome analysis with groundbreaking technologies for non-...

Series C
0-1 employees
Analytics, Biotechnology
Intelliseq vs
ingenetix GmbH
ingenetix GmbH Austria

Your partner for real-time PCR applications, gene expression analysis and pathogen detection assays

14 employees
Analytics, Biopharma
Intelliseq vs
GenePath Diagnostics
GenePath Diagnostics United States

Better Healthcare Through Next Generation Diagnostics

Venture round
56 employees
Biotechnology, Health Care
View all alternatives

FAQ About Intelliseq

Master Genomic Analysis: User-Friendly, Adaptable & Comprehensive solution for Professionals
Intelliseq was founded in 2013.
Intelliseq operates in AI, Analytics, Biotechnology and Health Care. Its work centres on Genomic Analysis, Next Generation Sequencing, Bioinformatics and Genetics.
Intelliseq has approximately 18 employees.
Intelliseq has completed 5 funding rounds, raising a total of $23.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Intelliseq include Personal Genome Diagnostics, ingenetix GmbH, GenePath Diagnostics, Strata Oncology, AVESTHAGEN LIMITED. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Intelliseq and Personal Genome Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Intelliseq, https://bouncewatch.com/company/intelliseq, updated 28 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes